Arctic Fox-Derived Lactiplantibacillus plantarum J3 Alleviates Colitis in Mice in Association with Strengthening of the Intestinal Barrier and Reshaping of the Intestinal Flora
Open Access
Abstract
Probiotic interventions for inflammatory bowel disease (IBD) have become a hot research topic in this field. However, no previous studies have investigated whether fox-derived probiotics exert therapeutic effects against colitis. The present investigation evaluated the effects of Lactiplantibacillus plantarum (syn. Lactobacillus plantarum) J3, sourced from the intestines of healthy Arctic foxes, on colitis. In an in vitro LPS-stimulated Caco-2 cell model, strain J3 exhibited prominent anti-inflammatory and antioxidant capacities, indicating potential to preserve intestinal barrier integrity. Furthermore, in an in vivo DSS-induced colitis mouse model, oral J3 supplementation markedly alleviated body weight loss, lowered disease activity index (DAI), and ameliorated histopathological lesions in colon tissues. Mechanistic analyses revealed that the J3 group displayed significantly decreased colonic levels of TNF-α, IL-1β, IL-6, MPO, PGE2, along with downregulated COX-2 mRNA expression (p < 0.05). By contrast, the levels of IL-10, TJ protein mRNA, and MUC2 mRNA were markedly upregulated, whereas serum LPS and D-Lac concentrations were significantly reduced (p < 0.05). In an exploratory analysis of 16S rDNA and short-chain fatty acids (SCFAs) in a subset of mice, J3 treatment showed a trend toward colonic microbial remodeling, accompanied by a significant increase in short-chain fatty acid production (p < 0.05). Overall, these findings indicate that Lactiplantibacillus plantarum J3 derived from foxes may alleviate DSS-induced colitis in mice, providing a basis for future translational research.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFD1302000)
This publication has 67 references indexed in Scilit:
- Crocin Supplementation Mitigates DSS ‐Induced Ulcerative Colitis by Promoting Autophagy and Modulating Gut Microbiota in MiceFood Science & Nutrition, 2026
- Lithocholic acid ameliorates ulcerative colitis via the PXR/TLR4/NF-κB/NLRP3 signaling pathway and gut microbiota modulationCellular and Molecular Life Sciences, 2025
- Alleviative effects of natural plant polysaccharides against DSS-induced ulcerative colitis via inhibiting inflammation and modulating gut microbiotaFood Research International, 2023
- Cell surface-associated protein elongation factor Tu interacts with fibronectin mediating the adhesion of Lactobacillus plantarum HC-2 to Penaeus vannamei intestinal epithelium and inhibiting the apoptosis induced by LPS and pathogen in Caco-2 cellsInternational Journal of Biological Macromolecules, 2022
- The long-term genetic stability and individual specificity of the human gut microbiomeCell, 2021
- The microbiome in inflammatory bowel diseases: from pathogenesis to therapyProtein & Cell, 2020
- Discovery of small-molecule candidates against inflammatory bowel diseaseEuropean Journal of Medicinal Chemistry, 2020
- Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel DiseasesCell Host & Microbe, 2017
- Gut microbiota functions: metabolism of nutrients and other food componentsEuropean Journal of Nutrition, 2017
- Optimizing anti-TNF treatments in inflammatory bowel diseaseAutoimmunity Reviews, 2014